Literature DB >> 27488858

HIV encephalitis with subcortical tau deposition: imaging pathology in vivo using F-18 THK 5117.

Madhavi Tripathi1, Saroj Yadav2, Vivek Kumar3, Rajeev Kumar3, Manjari Tripathi4, Shailesh Gaikwad5, Parveen Kumar3, Chandrasekhar Bal3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27488858     DOI： 10.1007/s00259-016-3473-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.

Authors:  Nobuyuki Okamura; Shozo Furumoto; Ryuichi Harada; Tetsuro Tago; Takeo Yoshikawa; Michelle Fodero-Tavoletti; Rachel S Mulligan; Victor L Villemagne; Hiroyasu Akatsu; Takayuki Yamamoto; Hiroyuki Arai; Ren Iwata; Kazuhiko Yanai; Yukitsuka Kudo
Journal:  J Nucl Med       Date:  2013-07-15       Impact factor: 10.057

2.  Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center.

Authors:  E Masliah; R K Heaton; T D Marcotte; R J Ellis; C A Wiley; M Mallory; C L Achim; J A McCutchan; J A Nelson; J H Atkinson; I Grant
Journal:  Ann Neurol       Date:  1997-12       Impact factor: 10.422

3.  Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.

Authors:  Christina Patrick; Leslie Crews; Paula Desplats; Wilmar Dumaop; Edward Rockenstein; Cristian L Achim; Ian P Everall; Eliezer Masliah
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

4.  Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy.

Authors:  Iain C Anthony; Stephen N Ramage; Frances W Carnie; Peter Simmonds; Jeanne E Bell
Journal:  Acta Neuropathol       Date:  2006-05-09       Impact factor: 17.088

Review 5.  Tau imaging in neurodegenerative diseases.

Authors:  M Dani; D J Brooks; P Edison
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-16       Impact factor: 9.236
  5 in total
  5 in total

Review 1.  Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV.

Authors:  Benedetta Milanini; Victor Valcour
Journal:  Curr HIV/AIDS Rep       Date:  2017-08       Impact factor: 5.071

Review 2.  Brain PET Imaging: Value for Understanding the Pathophysiology of HIV-associated Neurocognitive Disorder (HAND).

Authors:  Sanhita Sinharay; Dima A Hammoud
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

3.  The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.

Authors:  Leah H Rubin; Erin E Sundermann; David J Moore
Journal:  J Neurovirol       Date:  2019-01-22       Impact factor: 2.643

Review 4.  Bromodomains in Human-Immunodeficiency Virus-Associated Neurocognitive Disorders: A Model of Ferroptosis-Induced Neurodegeneration.

Authors:  Adonis Sfera; Karina G Thomas; Christina V Andronescu; Nyla Jafri; Dan O Sfera; Sarvin Sasannia; Carlos M Zapata-Martín Del Campo; Jose C Maldonado
Journal:  Front Neurosci       Date:  2022-05-12       Impact factor: 5.152

5.  Behavioral Evidence for a Tau and HIV-gp120 Interaction.

Authors:  Murali Vijayan; Linda Yin; P Hemachandra Reddy; Khalid Benamar
Journal:  Int J Mol Sci       Date:  2022-05-15       Impact factor: 6.208
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.